Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MEDX
#7175
Horizon Kinetics Medical ETF
33.5
3
USD
-0.68%
Setor:
Finanças
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.68%
Mudança mensal
+0.69%
Mudança em 6 meses
+7.09%
Mudança anual
+33.21%
Fechamento anterior
33.7
6
Abrir
33.5
3
Bid
Ask
Mínimo
33.5
3
High
33.5
3
Volume
1
Mercados
Ações
Finanças
MEDX
Abrir gráfico completo
Principais ativos
Market Value
Shares
Weight %
LLY
Eli Lilly & Co
3.46 M
3 218.00
18.25%
ABBV
AbbVie Inc
1.68 M
7 356.00
8.87%
US BANK MMDA - USBGFS 7
1.40 M
1.40 M
7.42%
NVS
Novartis AG
1.27 M
9 194.00
6.69%
AZN
AstraZeneca PLC
1.01 M
10.99 K
5.33%
JNJ
Johnson & Johnson
952.38 K
4 602.00
5.03%
IONS
Ionis Pharmaceuticals Inc
945.52 K
11.95 K
4.99%
ALNY
Alnylam Pharmaceuticals Inc
944.82 K
2 376.00
4.99%
BMY
Bristol-Myers Squibb Co
865.84 K
16.05 K
4.57%
AMGN
Amgen Inc
739.72 K
2 260.00
3.90%
MRK
Merck & Co Inc
677.45 K
6 436.00
3.58%
PFE
Pfizer Inc
618.12 K
24.82 K
3.26%
Alkermes PLC
617.41 K
22.07 K
3.26%
REGN
Regeneron Pharmaceuticals Inc
532.59 K
690.00
2.81%
CRISPR Therapeutics AG
530.38 K
10.11 K
2.80%
GSK
GSK PLC
529.24 K
10.79 K
2.79%
BIIB
Biogen Inc
525.86 K
2 988.00
2.78%
BEAM
Beam Therapeutics Inc
254.86 K
9 194.00
1.35%
VNDA
Vanda Pharmaceuticals Inc
218.95 K
24.82 K
1.16%
GALT
Galectin Therapeutics Inc
214.17 K
51.48 K
1.13%
Notícias
Medmix FY25 revenue falls, dividend cut 80%; shares down 17%
Medmix FY 2025: margens sobem 90 pontos-base enquanto receita cai 7,4%
Medmix FY 2025 slides: margins surge 90bps as revenue falls 7.4%
Earnings call transcript: Medmix sees margin growth amid revenue dip in H2 2025
Medical ETF (MEDX) Touches New 52-Week High
Stifel inicia cobertura da Medmix com recomendação de compra e preço-alvo de CHF 14,50
Stifel initiates coverage on Medmix stock with Buy rating, CHF14.50 target
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Horizon Kinetics Q3 2025 Commentary (HKHC)
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data